- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Focus on Women's Health
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Focus on Women's Health
- The New Administration: Enforcement and Legislative Impact
Capabilities
Strength and agility in exploiting, protecting and enforcing intellectual property rights is business-critical. Our full-service intellectual property practice combines proven first-chair trial lawyers with true technical specialists to defend our clients’ IP interests through:
- Patent litigation before district courts across the country, including the Eastern District of Texas, the District of Delaware, and the Central and Northern Districts of California
- Post-Grant proceedings, including inter partes review in front of the Patent Trial and Appeal Board (PTAB)
- Appellate courts and the International Trade Commission (ITC)
- Trademark Trial and Appeal Board (TTAB) proceedings
- Patent prosecution, counseling and IP due diligence
- Media and entertainment litigation, including leading-edge music and copyright matters
- Trademark, copyright, trade secret and false advertising litigation
Our IP litigators have handled hundreds of complex litigation matters across a diverse range of industry sectors, including most notably life sciences, telecommunications, computer systems, media and entertainment, biotech, consumer products, oil and gas, cosmetics, and food and beverage.
Our patent trial lawyers are extremely capable in obtaining the best results for our clients and are not afraid to litigate in the most complicated of cases. For many clients, the at-risk product revenues were in the billions of dollars per case.
Our IP practice has established a reputation as a go-to firm for IP appellate work. Our litigation teams make concerted efforts to include, where appropriate, appellate practitioners before, during and after trial to ensure the best record and the best results for the client.
In trademark and copyright litigation, our lawyers have represented clients in trials and preliminary injunction hearing, practiced in federal courts, the USPTO, TTAB and ITC, and participated in ICANN domain name arbitrations.
Our media and entertainment practice is right at the cutting edge of digital media and traditional media. Our team has particular experience in litigating copyright infringement and antitrust/rate-setting claims in cases involving the distribution of audio and audio-visual media content.
The majority of the team’s patent professionals hold technical degrees, with many having industry experience as well.
Related Lawyers
Insights
Client Alert
Article · Source: Law360
February 3, 2021
Challenging Therapeutics IP After Fed. Circ. Drink Can Ruling
Article · Source: Lexology
January 20, 2021
Digital Health 2021 Russia
Brochures
Close
Recognition
13 Partners Listed as "IP Stars"
Managing IP Handbook, 2020
Top Ranked Across Various Jurisdictions for Patent, Trademark, Copyright Law
Chambers USA, 2020
Ranked Tier 1 Nationally for Copyright Lititgation
Legal 500 US, 2020
Three Partners Ranked Band 2 for Trademark Law
World Trademark Review 1000, 2020
15 Partners Named to "Patent 1000"
Intellectual Asset Management, 2020
IP Partners Kenneth Steinthal, Gerald Flattmann, and Tim Barber Recognized as Top Litigators
Benchmark Litigation, 2020
Tier 1 Nationally for Litigation - Intellectual Property, Copyright Law, Patent Litigation, and Trademark Law
US News & World Report, 2020
Women in IP Group Received Chambers Award for "Most Innovative Networking Group"
Chambers USA, 2017
News
In the News · Source: Law360, Global Competition Review, IP STARS and The National Law Journal
In the News · Source: Law.com International
March 9, 2021
Marcus Young, Jules Quinn and Daniel Friel counsel QOMPLX on its deal with RPC
In the News · Source: Law360
March 8, 2021
Steven Zager and Gerald Flattmann advise GW Pharmaceuticals on its CBD-related patent dispute with Canopy Growth
Cases & Deals
February 26, 2021
King & Spalding advises Atlas Holdings on the sale of Merchants Metals LLC to The Sterling Group
December 1, 2020
Aaron's Completes Spin-Off Transaction